These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22612615)

  • 1. Shock, terror and controversy: how the media reacted to the Women's Health Initiative.
    Brown S
    Climacteric; 2012 Jun; 15(3):275-80. PubMed ID: 22612615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based assessment of the impact of the WHI on women's health.
    Burger HG; MacLennan AH; Huang KE; Castelo-Branco C
    Climacteric; 2012 Jun; 15(3):281-7. PubMed ID: 22612616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitfalls of the WHIs: Women's Health Initiative.
    Mastorakos G; Sakkas EG; Xydakis AM; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():331-40. PubMed ID: 17308158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
    Langer RD; Manson JE; Allison MA
    Climacteric; 2012 Jun; 15(3):206-12. PubMed ID: 22612605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and breast cancer risk 10 years after the WHI.
    Gompel A; Santen RJ
    Climacteric; 2012 Jun; 15(3):241-9. PubMed ID: 22612610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: dilemmas in 2002.
    Moore A
    Trans Am Clin Climatol Assoc; 2003; 114():233-8; discussion 238-40. PubMed ID: 12813923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy in the WHI era.
    Burger HG
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH; van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2127-30. PubMed ID: 12474550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.